# TRIM49D1

## Overview
TRIM49D1 is a gene that encodes the protein tripartite motif containing 49D1, which is a member of the tripartite motif (TRIM) family of proteins. These proteins are characterized by the presence of a RING finger domain, one or two B-box domains, and a coiled-coil region, which are involved in various cellular processes, including regulation of development, cell proliferation, and immune response. The TRIM49D1 protein is thought to play a role in modulating immune responses and neuronal function, as suggested by its downregulation in neuronal progenitor cells upon exposure to recombinant Apolipoprotein E3 (Geffin2017Apolipoprotein). Although the full spectrum of its biological functions and clinical significance is not yet fully elucidated, TRIM49D1 has been associated with chromosomal abnormalities in certain conditions, such as intellectual disability, indicating a potential area for further research (Zachaki2018A).

## Clinical Significance
The clinical significance of TRIM49D1, a member of the tripartite motif (TRIM) family, is not fully understood, but some studies have highlighted its potential involvement in certain conditions. In the context of HIV exposure, TRIM49D1 expression is notably downregulated in neuronal progenitor cells when exposed to recombinant Apolipoprotein E3 (rApoE3), suggesting a role in immune response modulation and possibly affecting neuronal function and excitability (Geffin2017Apolipoprotein).

A case study involving a pediatric patient with intellectual disability identified a microdeletion on chromosome 11, which included the TRIM49D1 gene. This deletion was part of a larger chromosomal abnormality, but the specific clinical significance of the TRIM49D1 deletion remains uncertain (Zachaki2018A). The study did not establish a direct link between TRIM49D1 and the intellectual disability observed in the patient, indicating that further research is needed to clarify its role in such conditions.

Overall, while TRIM49D1 is implicated in gene expression changes under certain pathological conditions, its precise clinical impact and potential as a therapeutic target require further investigation.


## References


[1. (Zachaki2018A) S Zachaki, E Kouvidi, A Mitrakos, L Lazaros, A Pantou, A Mavrou, M Tzetis, and KN Manola. A novel de novo paracentric inversion [inv(20)(q13.1q13.3)] accompanied by an 11q14.3-q21 microdeletion in a pediatric patient with an intellectual disability. Balkan Journal of Medical Genetics, 21(2):63–67, December 2018. URL: http://dx.doi.org/10.2478/bjmg-2018-0016, doi:10.2478/bjmg-2018-0016. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.2478/bjmg-2018-0016)

[2. (Geffin2017Apolipoprotein) Rebeca Geffin, Ricardo Martinez, Alicia de las Pozas, Biju Issac, and Micheline McCarthy. Apolipoprotein e4 suppresses neuronal-specific gene expression in maturing neuronal progenitor cells exposed to hiv. Journal of Neuroimmune Pharmacology, 12(3):462–483, March 2017. URL: http://dx.doi.org/10.1007/s11481-017-9734-9, doi:10.1007/s11481-017-9734-9. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11481-017-9734-9)